Kallikrein 11 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PA14312-Each-of-1 | In Stock | ₹ 46,502.50 |
PA14312 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
Kallikrein 11
Classification
Polyclonal
Conjugate
Unconjugated
Gene
Klk11
Gene Alias
2310015I08Rik; Hippostasin; hK11; kallikrein 11; kallikrein related peptidase 11; kallikrein related-peptidase 11; Kallikrein11; kallikrein-11; Kallikrein-11 inactive chain 1; Kallikrein-11 inactive chain 2; kallikrein-related peptidase 11; KLK11; protease, serine, 20; Prss20; Serine protease 20; TLSP; Trypsin-like protease; UNQ649/PRO1279
Host Species
Rabbit
Purification Method
Antigen affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
11012, 292849, 56538
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Gene Accession No.
Q9QYN3, Q9UBX7
Gene Symbols
Klk11
Immunogen
Synthetic peptide: Y(68) I V H L G Q H N L Q K E E G(82)
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- PA1-4312 detects the Hippostatin/KLK11 protein in human, mouse, and rat samples
- PA1-4312 has been successfully used in Western blot procedures
- By Western blot this antibody detects a ∽38 kDa protein representing KLK11 in LNCaP cell lysate
- PA1-4312 immunizing peptide corresponds to amino acid residues 68-82 of the 35 kDa human hippostasin/KLK11protein
- There is 86% sequence identity to mouse and rat
- Hippostasin, also known as KLK11, is a kallikrein-like serine protease, which has two alternatively spliced isoforms, brain-type and prostate-type
- Hippostasin plays a role in the prostate, including reproductive and/or tumorigenic functions
- Elevated serum levels of KLK11 were found in 70% of women with ovarian cancer and in 60% of men with prostate cancer
- Analysis of the KLK11 biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.